Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1501, 2005-01, pp. : 20-20
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Isotretinoin risk management to be strengthened in the US
Reactions Weekly, Vol. 1, Iss. 1030, 2004-01 ,pp. :
Access to resources
Recommend
Risk Management Policy and Black-Box Warnings: A Qualitative Analysis of US FDA Proceedings
Drug Safety, Vol. 32, Iss. 11, 2009-11 ,pp. :
US FDA warns of increased myopathy risk with Zocor
Reactions Weekly, Vol. 1, Iss. 1294, 2010-01 ,pp. :
US FDA lays out strategy for risk communication
Reactions Weekly, Vol. 1, Iss. 1273, 2009-01 ,pp. :